Related Experiment Video
Updated: Sep 21, 2026

In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Protease-activated receptor-2 (PAR2) in the airways
1Department of Pharmacology, The University of Melbourne, Victoria 3010, Australia.
Abstract:
Protease-activated receptors (PARs) act as sensors for active extracellular serine proteases. Since serine proteases like mast cell tryptase are associated with inflammatory processes, PARs may represent novel pharmacological targets in airway diseases like asthma and chronic obstructive pulmonary disease. However, our present understanding of the physiological roles of PARs is in its infancy. In this review we highlight evidence for the involvement of PARs in airway disease and propose that these novel receptors may play mainly protective roles.
Related Concept Videos
Receptor Tyrosine Kinases
MAPK Signaling Cascades
GPCR Desensitization
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Respiratory Syncytial Virus Disease
Chronic Obstructive Pulmonary Disease II: Emphysema

